GE Healthcare Closes Whatman Buy, Adding Lab Technologies to Dx Portfolio | GenomeWeb
NEW YORK (GenomeWeb News) – General Electric’s GE Healthcare unit said today that it has closed its purchase of the lab filtration company Whatman.
GE Healthcare signed the £363 million ($713 million at the time) agreement to acquire Whatman in early February. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.